Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
NIH-funded research reveals how oral GLP-1 medications penetrate deep into brain reward circuits, offering new pathways for treating substance use disorders beyond weight loss.
CDC study reveals gabapentin detection in overdose deaths increased significantly, with 85-90% of cases also involving opioids
Kentucky reports lowest overdose death toll since 2014, with 1,101 fatalities representing 50% decrease from 2021 peak
New research reveals 21% of opioid overdose survivors experience repeat overdoses within a year—far exceeding previous estimates—as fentanyl transforms the crisis landscape.
Forty-two addiction specialists establish consensus best practices for initiating medications for opioid use disorder in hospitals, adapting protocols for the fentanyl era.
Research identifies novel mechanism where oral GLP-1 medications penetrate deep into brain's reward center, opening potential pathways for treating addiction
JAMA study finds psychedelic-assisted therapy produced higher abstinence rates and longer relapse prevention than standard treatment
State commission recommends expanding low-barrier treatment and harm reduction as xylazine gives way to medetomidine in the illicit drug supply.
Tennessee becomes latest state to legalize FDA-approved ibogaine research, joining Texas and Arizona in studying the psychedelic for PTSD and opioid addiction treatment.